Colorectal Neoplasms Clinical Trials in Duarte, California
4 studies are recruiting for colorectal neoplasms in Duarte, California right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.
Search these by distance from you
Studies now recruiting
-
A Study of LY4257496 in Participants With Cancer (OMNIRAY)
The main purpose of this study is to evaluate safety, tolerability, and efficacy of LY4257496 alone and as part of relevant standard of care (SOC) combination therapy in participants with Gastrin-releasing Peptide Receptor (GRPR)-positive advanced cancer, including but not limited to breast, colore…
- Stage
- Phase 1
- Ages
- 18 and older
- Site
- City of Hope, Duarte, California
- Locations
- 33 in total
- Run by
- Eli Lilly and Company
-
A Study of SGN-CEACAM5C in Adults With Advanced Solid Tumors
This clinical trial is studying advanced solid tumors. Solid tumors are cancers that start in a part of your body like your lungs or liver instead of your blood. Once tumors have grown bigger in one place but haven't spread, they're called locally advanced. If your cancer has spread to other parts …
- Stage
- Phase 1
- Ages
- 18 and older
- Site
- City of Hope (City of Hope National Medical Center, City of Hope Medical Center), Duarte, California
- Locations
- 48 in total
- Run by
- Seagen, a wholly owned subsidiary of Pfizer
-
Early Onset Colorectal Cancer Detection
Colorectal cancer (CRC) once predominantly affected older individuals, but in recent years has witnessed a progressive increase in incidence among young adults. Once rare, early-onset colorectal cancer (EOCRC, that is, a CRC diagnosed before the age of 50) now constitutes 10-15% of all newly diagno…
- Stage
- Not phased
- Ages
- 18 to 50
- Site
- City of Hope Medical Center, Duarte, California
- Locations
- 13 in total
- Run by
- City of Hope Medical Center
-
Performance of SGM-101 for the Delineation of Primary and Recurrent Tumor and Metastases in Patients Undergoing Surgery for Colorectal Cancer
The performance of SGM-101, an intraoperative imaging agent, will be compared to that of standard "white light" visualization during surgical resections of colorectal cancer.
- Stage
- Phase 3
- Ages
- 18 and older
- Site
- City of Hope National Medical Center, Duarte, California
- Locations
- 11 in total
- Run by
- Surgimab
How to read this page. Every study here comes from ClinicalTrials.gov, the public registry that research teams are required to file with. We have summarised each one in plain language and shown where it is running. We have not changed what any study says it is doing.
What TrialBoost is. We help people find research that might suit them, and, if they ask us to, we pass their details to the research team running it. We are not a doctor, a research site, or a study sponsor, and we do not decide who takes part in anything. Joining costs nothing and you can change your mind at any point.
Paid placement. Some studies pay us when someone asks to be connected to them. Those are labelled Sponsored wherever they appear, and they only appear when they match what you were actually looking for.